Kolkata: With approximately 40.9 million
people in India diagnosed with diabetes and one in every six
estimated to have an ulcer during their lifetime, umbilical
cord banking technology will harvest the right stem cells for
them to prevent amputation, experts say.
"Umblical cord banking technology has been found to
produce proper stem cells to treat diabetic ulcer to avoid an
amputation," CEO of Singapore-based Cordlife group Steven
Fang said.
"Typically, diabetic ulcers are very difficult to
heal, but with epithelial stem cells, ulcers can be healed
within 45 days," he said.
Epithelial stem cells, he said, have the potential to
rejuvenate skin and mucus membrane to treat non-healing
wounds, particularly of patients with diabetic ulcers.
The advanced umbilical cord banking technology has an
unique abillity to isolate two cell types to help hasten the
healing of general and diabetic foot ulcers or repair injured
tissues and organs, he said.
"Our company is in the initial stage of identifying
prominent institutions and specialist physicians to provide
the application of epithelial stem cells on diabetics," he
added.
Fang said that Cordlife, a stem cell banking leader,
would provide the collection and storage of umbilical cord
stem cells as a value-added service for all cord blood
banking customers over a limited time.
Bureau Report